Kiniksa Entered into a Global License Agreement with Genentech to Develop and Commercialize Vixarelimab for Fibrosis
August 4, 2022
Kiniksa Collaborated with Huadong Medicine to Develop and Commercialize Arcalyst and Mavrilimumab for Autoimmune and Inflammatory...
February 23, 2022
Kiniksa Reports Results of Mavrilimumab in P-III Trial for the Treatment of COVID-19-Related ARDS
December 29, 2021
PharmaShots Weekly Snapshots (Mar 15 - 19, 2021)
March 19, 2021
Insights+: Breakthrough Therapy Designation by the US FDA in 2020
March 11, 2021
Insights+: COVID-19 Healthcare News Monthly Updates - June 2020
June 30, 2020
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.